Click on one of these terms to refine your search
1 to 10 of 50 stories
-
Dexferrum (iron dextran injection) - labeling change
Food and Drug Administration. - October 16, 2009Risk of anaphylactic-type reactions, including fatalities, have followed the parenteral administration of iron dextran injection.
-
Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
PR Newswire. - October 06, 2009 -
Study demonstrates potential of human Serum Amyloid P to block very aggressive fibrotic pathology
News-Medical. - November 04, 2009Promedior, Inc., a leader in the development of novel therapeutics for the treatment of fibrotic diseases and tissue remodeling, announced today the publication of results from preclinical studies demonstrating that human Serum Amyloid P (hSAP) potently inhibited fibrosis in two indep…
-
Glucosamine Fails Osteoarthritis Test news
e-Healthcare.Popular supplement doesn't prevent loss of cartilage in knee, study finds
-
Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans [Bone metabolism]
American journal. - October 20, 2009Background: Several clinical trials have reported B vitamins to be associated with osteoporosis.Objective: Our objective was to investigate whether low serum B vitamins are associated with altered structural and biomechanical properties of human bone.Design: Femoral heads of 94 men an…
-
Accelerated Healing of the Rat Achilles Tendon in Response to Autologous Conditioned Serum
American journal. - October 28, 2009BackgroundDespite advances in the treatment of ruptured Achilles tendon, imperfections of endogenous repair often leave patients symptomatic. Local administration of autologous conditioned serum (ACS) in patients with inflammatory, degenerative conditions has shown beneficial effects.…
-
XTEN Data From Amunix And Versartis Featured In Nature Biotechnology As A Novel Platform For Increasing Serum Half-Life Of Protein Therapeutics
Medical News Today. - November 17, 2009Amunix, Inc. and Versartis, Inc. announced today that the scientific journal Nature Biotechnology has published a comprehensive paper entitled "A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner." The paper (http://dx.doi.org/10.1038/n…
-
arGentis Pharmaceuticals to commence human clinical evaluation of ARG301 oral altered peptide ligand
News-Medical. - November 12, 2009arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG3…
-
Novelties: Mimicking Human Cartilage to Repair a Knee
My Times. - August 15, 2009An off-the-shelf plug inserted into the damaged area can guide formation of new bone and cartilage before dissolving in about six months.
-
Data advisory with regard to NHANES serum 25-hydroxyvitamin D data [Letters to the Editor]
American journal. - August 19, 2009
